Cell Biology: Research & TherapyISSN: 2324-9293

Reach Us +447480724769
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Chemotherapy Increases Aggressiveness of Prostate Cancer via Epithelial Mesenchymal Transition

Chemotherapy Increases Aggressiveness of Prostate Cancer via Epithelial Mesenchymal Transition

Although chemotherapy has been used as a major therapeutic weapon against advanced prostate cancer, overcoming drug resistance is still a major challenge. Cancer has been known to diminish therapeutic effect by several molecular mechanisms– increasing efflux by recruiting cell membrane pumps and limiting drug diffusion by constructing leaky vasculature. Moreover, recent studies suggest that long-term treatment with chemotherapy may have detrimental effects for patients presenting with solid tumors. Specifically, prostate cancer epithelial cells develop resistance to chemotherapy and may convert into mesenchymal cells. This switching process, known as Epithelial to Mesenchymal Transition (EMT), is a critical precursor in prostate cancer invasion and metastasis.

Special Features

Full Text

View

Track Your Manuscript

Share This Page

Media Partners

Associations